Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study

Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes

(2013) Travis E. Grotz et al.   MELANOMA RESEARCH

Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia

(2012) Adèle C. Green et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma

(2012) Farhad Azimi et al.   JOURNAL OF CLINICAL ONCOLOGY

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

(2012) J. M. Taube et al.   Science Translational Medicine

Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma

(2011) Trine O. Jensen et al.   CANCER

An immune-active tumor microenvironment favors clinical response to ipilimumab

(2011) Rui-Ru Ji et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

AJCC melanoma staging update: impact on dermatopathology practice and patient management

(2011) Adriano Piris et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

(2011) Paul B. Chapman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Presence of Tumor-Infiltrating Lymphocytes and a Dominant Nodule Within Primary Melanoma Are Prognostic Factors for Relapse-Free Survival of Patients With Thick (T4) Primary Melanoma

(2010) Uma N. M. Rao et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

2010 TNM Staging System for Cutaneous Melanoma…and Beyond

(2010) Jeffrey E. Gershenwald et al.   ANNALS OF SURGICAL ONCOLOGY

Gene Signature in Melanoma Associated With Clinical Activity

(2010) Thomas F. Gajewski et al.   CANCER JOURNAL

Tumor Location Predicts Survival in Cutaneous Head and Neck Melanoma

(2010) Warren H. Tseng et al.   JOURNAL OF SURGICAL RESEARCH

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database

(2009) M. Mandalà et al.   EUROPEAN JOURNAL OF CANCER

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program

(2008) Anne M. Lachiewicz et al.   ARCHIVES OF DERMATOLOGY

Innate immunity and aging

(2008) Christian R. Gomez et al.   EXPERIMENTAL GERONTOLOGY

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression

(2008) Inge S. van Houdt et al.   INTERNATIONAL JOURNAL OF CANCER